J3305 – Injection, trimetrexate glucuronate, per 25 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ3305
- Long description
- Injection, trimetrexate glucuronate, per 25 mg
- Short description
- Inj trimetrexate glucoronate
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- January 1, 1996
- Last change
- January 1, 2026 – No change
- Termination date
- December 31, 2025
Frequently asked questions
What is HCPCS code J3305?
J3305 is a HCPCS Level II code for injection, trimetrexate glucuronate, per 25 mg. It was discontinued on December 31, 2025.
Does Medicare cover J3305?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J3290 – Injection, tranexamic acid, 5 mg
- J3291 – Injection, tranexamic acid in sodium chloride, 5 mg
- J3299 – Injection, triamcinolone acetonide (xipere), 1 mg
- J3300 – Injection, triamcinolone acetonide (triesence), preservative free, 1 mg
- J3301 – Injection, triamcinolone acetonide, not otherwise specified, 10 mg
- J3302 – Injection, triamcinolone diacetate, per 5 mg
- J3303 – Injection, triamcinolone hexacetonide, per 5 mg
- J3304 – Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
- J3310 – Injection, perphenazine, up to 5 mg
- J3315 – Injection, triptorelin pamoate, 3.75 mg
- J3316 – Injection, triptorelin, extended-release, 3.75 mg
- J3320 – Injection, spectinomycin dihydrochloride, up to 2 gm
- J3350 – Injection, urea, up to 40 gm
- J3355 – Injection, urofollitropin, 75 iu
- J3357 – Ustekinumab, for subcutaneous injection, 1 mg
- J3358 – Ustekinumab, for intravenous injection, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.